Yoghurt biotherapy: contraindicated in immunosuppressed patients?
Open Access
- 1 June 2002
- journal article
- case report
- Published by Oxford University Press (OUP)
- Vol. 78 (920) , 366-367
- https://doi.org/10.1136/pmj.78.920.366
Abstract
AUTHOR:e-mail address please A fatal case of Lactobacillus rhamnosus septicaemia after prolonged oral vancomycin for recalcitrant Clostridium difficile infection is reported. The patient was immunosuppressed with cyclophosphamide and steroids for Sjögren's syndrome. The administration of Lactobacillus spp as “biotherapy” may be hazardous in such circumstances.Keywords
This publication has 7 references indexed in Scilit:
- Lactobacillus Endocarditis: A Chronic Active InfectionCardiovascular Pathology, 1997
- Lactobacillus species as emerging pathogens in neutropenic patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1997
- Effect of Vancomycin on Intestinal Flora of Patients Who Previously Received Antimicrobial TherapyClinical Infectious Diseases, 1997
- Lactobacillus Bacteremia: Description of the Clinical Course in Adult Patients Without EndocarditisClinical Infectious Diseases, 1996
- Biotherapy for antibiotic-associated and other diarrhoeasJournal of Infection, 1996
- Lactic Acid Bacteria in the Treatment of Acute Rotavirus GastroenteritisJournal of Pediatric Gastroenterology and Nutrition, 1995
- Vancomycin resistance of clinical isolates of lactobacilliJournal of Infection, 1988